A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer.
Phase of Trial: Phase III
Latest Information Update: 25 Jun 2011
At a glance
- Drugs Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms Nordic-VI
- 25 Jun 2011 Quality of life results presented at the 13th World Congress on Gastrointestinal Cancer.
- 05 Nov 2010 New trial record.